News
Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...
CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.
Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).
Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results